Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research
Published on: March 22, 2024
The glycemic gap as a prognostic indicator in cardiogenic shock: a retrospective cohort study
Qianqian Xu1, Jinsheng Wang1, Zhihui Lin1
1Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Xueyuanxi Road, No 109, Wenzhou , Zhejiang, 325027, China.
Insights
The glycemic gap (GG) indicates stress-induced hyperglycemia and predicts poor outcomes in cardiogenic shock (CS) patients, irrespective of diabetes. Higher GG levels correlate with increased 30-day mortality and lactic acid levels in CS.
Area of Science:
- Cardiology
- Endocrinology
- Critical Care Medicine
Background:
- Stress-induced hyperglycemia (SIH) is linked to adverse outcomes in cardiogenic shock (CS).
- The glycemic gap (GG), calculated as blood glucose minus A1c-derived average glucose, is a key indicator of SIH.
- Previous studies show inconsistent results regarding SIH and outcomes in CS patients with or without diabetes mellitus (DM).
Purpose of the Study:
- To investigate the prognostic role of the glycemic gap (GG) in patients with cardiogenic shock (CS).
- To explore the association between GG and 30-day mortality in CS patients.
- To examine the correlation between GG and lactic acid levels in CS.
Main Methods:
- Utilized data from the MIMIC-IV v2.0 database for CS patients to assess GG and 30-day mortality.
- Included CS patients from the Second Affiliated Hospital of Wenzhou Medical University to analyze GG and lactic acid correlation.
- Applied multivariate analysis, propensity score-matched (PSM) analysis, and inverse probability treatment weighting (IPTW).
Main Results:
- Both absolute and relative glycemic gaps (GG) were significantly associated with increased 30-day all-cause mortality in CS patients.
- Higher GG levels correlated with elevated lactic acid, indicating increased severity.
- GG improved the predictive value of the Glasgow Coma Scale (GCS) for mortality, irrespective of diabetes status.
Conclusions:
- The glycemic gap (GG) is a valuable predictor of 30-day mortality in cardiogenic shock (CS) patients, independent of diabetes mellitus (DM).
- GG reflects CS severity and is linked to hyperlactatemia and insulin resistance.
- GG enhances the prognostic capability of existing clinical scores like the GCS.
Background:
Stress-induced hyperglycemia (SIH) is associated with poor outcomes in cardiogenic shock (CS), and there have been inconsistent results among patients with or without diabetes mellitus (DM). The glycemic gap (GG) is derived by subtracting A1c-derived average glucose from blood glucose levels; it is a superior indicator of SIH. We aimed to explore the role of GG in the outcomes of patients with CS.
Methods:
Data on patients diagnosed with CS were extracted from the MIMIC-IV v2.0 database to investigate the relationship between GG and 30-day mortality (Number of absolute GG subjects = 359; Number of relative GG subjects = 357). CS patients from the Second Affiliated Hospital of Wenzhou Medical University were enrolled to explore the correlation between GG and lactic acid (Number of absolute GG subjects = 252; Number of relative GG subjects = 251). Multivariate analysis, propensity score-matched (PSM) analysis, inverse probability treatment weighting (IPTW), and Pearson correlation analysis were applied.
Results:
Absolute GG was associated with 30-day all-cause mortality in CS patients (HRadjusted: 1.779 95% CI: 1.137-2.783; HRPSM: 1.954 95% CI: 1.186-3.220; HRIPTW: 1.634 95% CI: 1.213-2.202). The higher the absolute GG level, the higher the lactic acid level (βadjusted: 1.448 95% CI: 0.474-2.423). A similar trend existed in relative GG (HRadjusted: 1.562 95% CI: 1.003-2.432; HRPSM: 1.790 95% CI: 1.127-2.845; HRIPTW: 1.740 95% CI: 1.287-2.352; βadjusted:1.294 95% CI: 0.369-2.219). Subgroup analysis showed that the relationship existed irrespective of DM. The area under the curve of GG combined with the Glasgow Coma Scale (GCS) for 30-day all-cause mortality was higher than that of GCS (absolute GG: 0.689 vs. 0.637; relative GG: 0.688 vs. 0.633). GG was positively related to the triglyceride-glucose index. Kaplan-Meier curves revealed that groups of higher GG with DM had the worst outcomes. The outcomes differed among races and GG levels (all P < 0.05).
Conclusions:
Among patients with CS, absolute and relative GGs were associated with increased 30-day all-cause mortality, regardless of DM. The relationship was stable after multivariate Cox regression analysis, PSM, and IPTW analysis. Furthermore, they reflect the severity of CS to some extent. Hyperlactatemia and insulin resistance may underlie the relationship between stress-induced hyperglycemia and poor outcomes in CS patients. They both improve the predictive efficacy of the GCS.
Related Concept Videos
Hypoglycemia and Glucagon
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Diabetes Mellitus: Type 2 and Gestational
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

